TrialArthritis research & therapy2020

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial.

Philip Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.